Pharmaceutical Labeling Compliance Basics: A Practical Guide

Ask five quality managers at five different pharmaceutical companies what "labeling compliance" means, and you'll likely get five different answers, one thinking about NDC formatting, another about UDI carriers, another about DSCSA serialization, another about label material validation, another about translation accuracy for a multi-market launch. They're all right. Pharmaceutical labeling compliance isn't one requirement; it's a stack of overlapping regulatory obligations that all must be satisfied by the same few square inches of a package.

This guide breaks down what that stack contains, in plain language, for teams who need a working map rather than a legal treatise.

The core layers of pharmaceutical labeling compliance

1. Content and formatting requirements (21 CFR Part 201, Part 801). This is the baseline: proprietary and established names, strength, dosage form, route of administration, National Drug Code(NDC), manufacturer information, storage conditions, and required warnings. Content requirements differ for prescription vs. OTC products and are the layer most teams think of first, but it's only the first layer.

2. Machine-readable identification. Since the FDA's 2013 Unique Device Identification (UDI) final rule, most medical devices must carry a UDI on their label in both human-readable plain text and an automatic identification and data capture (AIDC) format, typically a barcode. The UDI has two parts: a fixed Device Identifier (DI) that identifies the labeler and specific version or model, and a variable Production Identifier(PI) that can include lot number, serial number, expiration date, and manufacture date. Pharmaceutical products use an analogous structure built around the NDC, typically encoded in a GS1 DataMatrix barcode.

3. Serialization and traceability (DSCSA). The Drug Supply Chain Security Act requires unit-level serialization for prescription drugs, a GS1 DataMatrix encoding the product's GTIN, lot number, expiration date, and a unique serial number, plus interoperable electronic data exchange between trading partners. Enforcement has moved through staggered deadlines by trading-partner type (manufacturers, wholesale distributors, large and small dispensers), with most of the supply chain now fully in scope. A label that can't be reliably scanned at every handoff doesn't just fail a quality check; it breaks the chain-of-custody data DSCSA requires.

4. Barcode quality, not just barcode presence. A barcode that's technically present but degrades under handling, print wear, or environmental exposure creates the same downstream problem as no barcode a tall: unscannable product, manual workarounds, and data gaps. Barcode grading(per ISO/IEC 15416 and ANSI standards) is the objective way to confirm a barcode will perform in the field, not just on the day it was printed.

5. Label material performance. Pharmaceutical labels face conditions most commercial packaging never sees cold-chain storage, autoclave or gamma sterilization, alcohol and disinfectant wipe-downs, humidity swings during global distribution, and multi-year shelf lives for some products. A label spec that isn't validated against the product's actual storage and handling conditions is a compliance gap waiting to surface at the worst possible moment, typically an audit or a return.

Where compliance programs most often break down

• Content compliance is treated as "done" once approved, and never revisited as pack sizes, markets, or regulations change, leading to labels that were compliant at approval but drift out of compliance as SKUs proliferate.
• Barcode verification happens only at initial qualification, not as an ongoing in-line check, so print-quality drift on a well-worn printhead goes undetected until a distributor or pharmacy can't scan the product.
• Label material selection is treated as a cost decision rather than a compliance and risk decision, particularly for the "final mile", pharmacy, hospital, or patient facing labels that get less packaging engineering attention than primary manufacturing labels.
• Serialization data and physical label design are managed by separate teams (IT/serialization vs. packaging/label design), creating a gap where the barcode encodes correctly in the system but doesn't print correctly on the label.

A practical starting checklist

• Confirm your current label content against the latest approved labeling text for every active SKU, not just new launches.
• Verify that UDI/NDC barcodes meet ISO/IEC 15416 grading requirements under production conditions, not just at intial validation.
• Confirm DSCSA serialization data (GTIN, lot, expiration, serial number) is correctly encoded and matches the physical label, a common failure point is a system-correct serial number encode onto a label that then prints with insufficient contrast or resolution to scan reliably.
• Validate label materials against the full range of conditions the product will face cold chain, sterilization method, handling, and shelf life, not just ambient room conditions.
• Build barcode verification into your process at the point of print, not only at incoming inspection of pre-printed labels

FAQ

What's the difference between UDI and DSCSA requirements?‍

UDI (Unique Device Identification) is an FDA requirement primarily for medical devices, identifying the device and its lot/serial/expiration data. DSCSA (Drug Supply Chain Security Act) is a separate requirement specific to prescription drugs, focused on unit-level serialization and interoperable electronic traceability across the supply chain. A combination product may need to satisfy both.

Do all pharmaceutical labels need a 2D barcode?

Serialized prescription drug units under DSCSA require a GS1 DataMatrix (2D) barcode encoding GTIN, lot, expiration date, and serial number. Medical devices under the UDI rule require AIDC technology as well, most commonly a barcode, though the specific symbology depends on the issuing agency and device type.

How often should barcode quality be verified?

At minimum, at label and packaging validation. Best practice is in-line verification at the point of print or application, since barcode print quality degrades gradually with printhead wear, ribbon quality, and label material, issues that a one-time validation won't catch.

Ahearn & Soper's ProVision Labels and barcode verification systems help pharmaceutical manufacturers and packagers meet UDI, DSCSA, and label-material validation requirements without slowing down the line. Talk to our team about barcode verification or request a service call.

‍